Transforming Growth Factor Beta Receptor 2 (TGFBR2) Promoter Region Polymorphisms May Be Involved in Mandibular Retrognathism

被引:8
|
作者
Kirschneck, Margarita [1 ]
Zbidat, Nermien [1 ]
Paddenberg, Eva [1 ]
Reis, Caio Luiz Bitencourt [2 ]
Madalena, Isabela Ribeiro [3 ,4 ,5 ]
de Menezes-Oliveira, Maria Angelica Hueb [6 ]
Lepri, Cesar Penazzo [6 ]
Proff, Peter [1 ]
Kirschneck, Christian [1 ]
Kuechler, Erika Calvano [1 ]
机构
[1] Univ Regensburg, Dept Orthodont, Regensburg, Germany
[2] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Pediat Dent, Ribeirao Preto, Brazil
[3] Univ Regiao Joinville, Dept Dent, Joinville, Brazil
[4] Presidente Tancredo Almeida Neves Univ Ctr, Sch Dent, Sao Joao Del Rei, Brazil
[5] Univ Fed Juiz de Fora, Sch Dent, Dept Restorat Dent, Juiz De Fora, Brazil
[6] Sch Dent Uberaba, Dept Masters Program Dent, Uberaba, Brazil
关键词
GENE POLYMORPHISMS; DIFFERENTIATION; MUTATIONS; DELETION; DEFECTS;
D O I
10.1155/2022/1503052
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Skeletal malocclusions are common phenotypes in humans and have a strong influence on genetic factors. Transforming growth factor beta (TGF beta) controls numerous functions of the human body, including cell proliferation, differentiation, and migration. Thus, this study is aimed at evaluating whether genetic polymorphisms in TGFB1 and its receptor TGFBR2 are associated with mandibular retrognathism in German children and adolescents. Children and teenagers older than 8 years in the mixed or permanent dentition were included in this study. Patients with syndromes and facial trauma and patients with congenital alterations were excluded. Digital cephalometric tracings were performed using the anatomical landmarks point A, point B, sella (S), and nasion (N). Patients that have a retrognathic mandible (SNB < 78 & DEG;) were selected as case group, and the patients with an orthognathic mandible (SNB=78 & DEG;- 82 & DEG;) were selected as the control group. Genomic deoxyribonucleic acid (DNA) from saliva was used to evaluate four genetic polymorphisms in TGFB1 (rs1800469 and rs4803455) and TGBR2 (rs3087465 and rs764522) using real-time PCR. Chi-square or Fisher exact tests were used to compare gender, genotype, and allele distribution among groups. Genotype distribution was calculated in an additive and recessive model. Haplotype analysis was also performed. The established alpha of this study was 5%. A total of 146 patients (age ranging from 8 to 18 years) were included in this epidemiological genetic study. The genetic polymorphism rs3087465 in TGFBR2 was associated with mandibular retrognathism. Carrying the AA genotype in the rs3087465 polymorphism decreased the chance of having mandibular retrognathism (odds ratio=0.25, confidence interval 95%=0.06 to 0.94, p=0.045). None of the haplotypes was associated with mandibular retrognathism (p > 0.05). In conclusion, we found that the genetic polymorphism rs3087465 in the promoter region of the TGFBR2 was associated with mandibular retrognathism in Germans.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism
    Yasri, Sora
    Wiwanitkit, Viroj
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 713 - 713
  • [2] Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism
    Sora Yasri
    Viroj Wiwanitkit
    Breast Cancer Research and Treatment, 2019, 178 : 713 - 713
  • [3] Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”
    Glauco Akelinghton Freire Vitiello
    Marla Karine Amarante
    Bruna Karina Banin-Hirata
    Clodoaldo Zago Campos
    Karen Brajão de Oliveira
    Roberta Losi-Guembarovski
    Maria Angelica Ehara Watanabe
    Breast Cancer Research and Treatment, 2020, 179 : 519 - 520
  • [4] Authors' reply to the comment "Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism"
    Freire Vitiello, Glauco Akelinghton
    Amarante, Marla Karine
    Banin-Hirata, Bruna Karina
    Campos, Clodoaldo Zago
    de Oliveira, Karen Brajao
    Losi-Guembarovski, Roberta
    Ehara Watanabe, Maria Angelica
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 519 - 520
  • [5] Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population
    Yun, J. Y.
    Uhm, Y. K.
    Kim, H. J.
    Lim, S. H.
    Chung, J. -H.
    Shin, M. -k.
    Yim, S. -V.
    Lee, M. -H.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2010, 37 (04) : 289 - 291
  • [6] Transforming growth factor beta receptor 2 (Tgfbr2) deficiency in keratocytes results in corneal ectasia
    Wang, Yen-Chiao
    Zolnik, Olivia Betty
    Yasoda, Shingo
    Yeh, Lung-Kun
    Yuan, Yong
    Kao, Winston
    Saika, Shizuya
    Liu, Chia-Yang
    OCULAR SURFACE, 2023, 29 : 557 - 565
  • [7] Correlations of androgen receptor (AR) and transforming growth factor beta receptor type 2 (TGFbR2) expression in prostate cancer (PCa)
    Puchinskaya, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1370 - S1370
  • [9] Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer
    S Mishra
    J J Deng
    P S Gowda
    M K Rao
    C-L Lin
    C L Chen
    T Huang
    L-Z Sun
    Oncogene, 2014, 33 : 4097 - 4106
  • [10] Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes
    Glauco Akelinghton Freire Vitiello
    Marla Karine Amarante
    Bruna Karina Banin-Hirata
    Clodoaldo Zago Campos
    Karen Brajão de Oliveira
    Roberta Losi-Guembarovski
    Maria Angelica Ehara Watanabe
    Breast Cancer Research and Treatment, 2019, 178 : 207 - 219